Kevin Charles Gorman, Director: Neurocrine Biosciences NBIX Sell · Filed 25/08/11

Trade details

Type: Insider sale
Amount: $13,440,164.02
Shares · price: 106,322 sh · $126.41 a share
Held after: 514,596 sh
Stock: Neurocrine Biosciences NBIX
Person: Kevin Charles GormanDirector
Trade date: 25/08/07
Filed: 25/08/11
Days to filing: 4 days

Sold 17.1% of holdings

Share of holding sold: 17.1%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/07/08~25/09/06

Kevin Charles Gorman's recent trades

Kevin Charles GormanDirector
Sell10b5-1 planXencor
Sell10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/17
Traded 06/15
Kevin Charles GormanDirector
Planned sale10b5-1 planXencor
Planned sale10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/15
Traded 06/15
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$37.8M
245,088 sh
$37.8M
Filed 05/21
Traded 05/19
Kevin Charles GormanDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$38.5M
245,088 sh
$38.5M
Filed 05/19
Traded 05/19
Kevin Charles GormanDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$13.7M
106,322 sh
$13.7M
Filed 25/08/07
Traded 25/08/07